GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation
OSL:GENT • NO0010748866
Current stock price
40.1 NOK
-2.2 (-5.2%)
Last:
This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GENT.OL Profitability Analysis
1.1 Basic Checks
- In the past year GENT was profitable.
- In the past year GENT had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: GENT reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
- GENT has a better Return On Assets (5.13%) than 69.84% of its industry peers.
- Looking at the Return On Equity, with a value of 6.47%, GENT is in line with its industry, outperforming 47.62% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 8.73%, GENT is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROIC | 8.73% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 7.51%, GENT is doing good in the industry, outperforming 60.32% of the companies in the same industry.
- GENT has a better Operating Margin (14.42%) than 71.43% of its industry peers.
- GENT has a Gross Margin (55.64%) which is in line with its industry peers.
- GENT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
2. GENT.OL Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
- GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- GENT has an Altman-Z score of 8.39. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
- GENT has a Altman-Z score of 8.39. This is amongst the best in the industry. GENT outperforms 93.65% of its industry peers.
- The Debt to FCF ratio of GENT is 0.61, which is an excellent value as it means it would take GENT, only 0.61 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.61, GENT belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
- GENT has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
- GENT has a better Debt to Equity ratio (0.09) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Altman-Z | 8.39 |
ROIC/WACC1.02
WACC8.53%
2.3 Liquidity
- A Current Ratio of 5.40 indicates that GENT has no problem at all paying its short term obligations.
- GENT has a Current ratio of 5.40. This is amongst the best in the industry. GENT outperforms 96.83% of its industry peers.
- GENT has a Quick Ratio of 3.81. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
- GENT has a Quick ratio of 3.81. This is amongst the best in the industry. GENT outperforms 95.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 |
3. GENT.OL Growth Analysis
3.1 Past
- The earnings per share for GENT have decreased strongly by -70.75% in the last year.
- Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 16.07% in the last year.
- Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 22.75% on average per year.
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
3.2 Future
- The Earnings Per Share is expected to grow by 79.21% on average over the next years. This is a very strong growth
- Based on estimates for the next years, GENT will show a quite strong growth in Revenue. The Revenue will grow by 19.00% on average per year.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GENT.OL Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 47.18, which means the current valuation is very expensive for GENT.
- Based on the Price/Earnings ratio, GENT is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
- GENT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.34.
- The Price/Forward Earnings ratio is 15.01, which indicates a correct valuation of GENT.
- GENT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GENT is cheaper than 68.25% of the companies in the same industry.
- GENT is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.18, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.18 | ||
| Fwd PE | 15.01 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as GENT.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 74.60% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.43 | ||
| EV/EBITDA | 16.37 |
4.3 Compensation for Growth
- GENT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as GENT's earnings are expected to grow with 79.21% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%
5. GENT.OL Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.46%, GENT has a reasonable but not impressive dividend return.
- The stock price of GENT dropped by -31.57% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
- Compared to an average industry Dividend Yield of 1.23, GENT pays a bit more dividend than its industry peers.
- GENT's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 46.54% of the earnings are spent on dividend by GENT. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Fundamentals: All Metrics, Ratios and Statistics
OSL:GENT (4/14/2026, 3:58:49 PM)
40.1
-2.2 (-5.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap618.34M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (60.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.46% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.18 | ||
| Fwd PE | 15.01 | ||
| P/S | 3.5 | ||
| P/FCF | 19.43 | ||
| P/OCF | 14.52 | ||
| P/B | 3.02 | ||
| P/tB | 3.66 | ||
| EV/EBITDA | 16.37 |
EPS(TTM)0.85
EY2.12%
EPS(NY)2.67
Fwd EY6.66%
FCF(TTM)2.06
FCFY5.15%
OCF(TTM)2.76
OCFY6.89%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.23
PEG (5Y)N/A
Graham Number15.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.13% | ||
| ROE | 6.47% | ||
| ROCE | 11.34% | ||
| ROIC | 8.73% | ||
| ROICexc | 16.54% | ||
| ROICexgc | 23.72% | ||
| OM | 14.42% | ||
| PM (TTM) | 7.51% | ||
| GM | 55.64% | ||
| FCFM | 18.03% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.61 | ||
| Debt/EBITDA | 0.56 | ||
| Cap/Depr | 118.04% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 123.21% | ||
| Profit Quality | 240.13% | ||
| Current Ratio | 5.4 | ||
| Quick Ratio | 3.81 | ||
| Altman-Z | 8.39 |
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
What is the profitability of GENT stock?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
What are the PE and PB ratios of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 47.18 and the Price/Book (PB) ratio is 3.02.
What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?
The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.